학술논문
Potential benefit from the implementation of the Kaiser Permanente neonatal early-onset sepsis calculator on clinical management of neonates with presumed sepsis.
Document Type
Article
Author
Kopsidas, Ioannis; Molocha, Nafsika-Maria; Kourkouni, Eleni; Coffin, Susan; Gkentzi, Despoina; Chorianopoulou, Evangelia; Dimitriou, Gabriel; Kapetanaki, Anastasia; Karavana, Georgia; Lithoxopoulou, Maria; Polychronaki, Maria; Roilides, Emmanuel; Triantafyllidou, Pinelopi; Triantafyllou, Christos; Tsopela, Grammatiki-Christina; Tsouvala, Emmanouela; Tsolia, Maria N.; Zaoutis, Theoklis; Spyridis, Nikos; For the PHiG Investigators: Vassiliki Papaevangelou; Asimina Tsintoni; Vasiliki Soubasi-Griva; Marianna Skordala- Riti; Maria Theodoraki
Source
Subject
*ANTIBIOTICS
*CLINICAL pathology
*PUBLIC health surveillance
*NEONATAL sepsis
*NEONATAL intensive care
*OPERATIVE surgery
*NEONATAL intensive care units
*DISEASE incidence
*HUMAN services programs
*TREATMENT effectiveness
*MEDICAL care research
*HOSPITAL care
*EMPIRICAL research
*SENSITIVITY & specificity (Statistics)
*NEONATOLOGY
*LONGITUDINAL method
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
0340-6199
Abstract
To assess the potential benefit from the implementation of the Kaiser Permanente early-onset sepsis calculator (EOS-C), in terms of antibiotic use and requested laboratory tests, in a network of neonatal intensive care units (NICUs) in Greece, and to determine the incidence of early-onset sepsis (EOS) in Greek NICUs, a prospective surveillance study was conducted in 7 NICUs between April 2018 and June 2019. Data were collected for all newborns ≥ 34 weeks' gestation receiving empiric antibiotic therapy within the first 3 days of life. The number of live births and positive blood or cerebrospinal fluid cultures within the first 3 days of life were used for calculation of EOS incidence. Evaluation of possible impact of implementing the calculator was done by comparing the clinicians' recorded management to the calculator's suggested course of action. The unit-specific incidence of culture-proven EOS ranged between 0 and 2.99/1000 live births. The weighted incidence rate for all 7 units was 1.8/1000 live births. Management of EOS guided by the calculator could lead to a reduction of empiric antibiotic initiation up to 100% for the group of "well-appearing" neonates and 86% for "equivocal," lowering exposure to antibiotics by 4.2 and 3.8 days per neonate, respectively. Laboratory tests for blood cultures drawn could be reduced by up to 100% and 68%, respectively. Sensitivity of the EOS-C in identifying neonates with positive blood cultures was high. Conclusion: Management strategies based on the Kaiser Permanente neonatal sepsis calculator may significantly reduce antibiotic exposure, invasive diagnostic procedures, and hospitalizations in late preterm and term neonates. What is Known: • Neonates are frequently exposed to antibiotics for presumed EOS. • The Kaiser Permanente sepsis calculator can reduce antibiotic exposure in neonates.. What is New: • EOS calculator can be an effective antibiotic stewardship tool in a high prescribing country and can reduce invasive diagnostic procedures and mother-baby separation. • Incidence of EOS in Greece is higher compared to other European countries. [ABSTRACT FROM AUTHOR]